Tokamak Energy Ltd

Fusion is the energy source of the Sun and stars. In the tremendous heat and gravity at the core of these stellar bodies, hydrogen nuclei collide, fuse into heavier helium atoms, and release huge amounts of energy in the process. Three conditions must be fulfilled to achieve fusion in a laboratory: very high temperature (on the order of 150,000,000 °C); s...

The need for secure, clean, reliable, and sustainable sources of energy has grown in both importance and urgency. Part of the solution to meet these needs is nuclear fusion. While experimental progress in fusion has evidenced its viability, a range of engineering challenges must be met and coordinated before fusion reactors can operate reliably for long p...

Tokamak Energy (TE) has unlocked a potential new route to scalable fusion power that is cost-effective and does not require huge infrastructure and capital expenditure. The technology will revolutionise world energy production -- it will be possible to produce more energy, more cheaply and with fewer undesirable consequences than existing technologies (e....

To model plasma turbulence to demonstrate that a high magnetic field spherical tokamak is internationally marketable as a scientific instrument for fusion R&D.

Fusion power has the potential to be clean, green and plentiful. It is inherently safe and carries no risks of nuclear proliferation. Projections of future world energy supply anticipate fusion power being responsible for 36% of all global electricity production by the year 2100. However, with the present R&D proposals, including the €15bn investment in t...

Culham Laboratory currently leads the world in the science and technology of tokamaks and magnetic confinement fusion. This is the most promising technology for the huge, long term, challenge of producing electricity from fusion. This project aims to establish the market demand for small tokamaks. In particular we will investigate the market for a small t...

The business opportunity that this project addresses has been summarised in the editorial and main feature article in The Engineer published on 11 April 2011. In the words of the Editor: “The medical industry relies on nuclear fission for the production of radioactive isotopes – which are essential for a range of scanning techniques and cancer treatments....